News

On a pro forma non-GAAP basis, the company recorded net income of $1.13 billion, or $1.04 per share in the third quarter of 2008, compared with third-quarter 2007

The Phase I clinical trial was designed to assess the safety, pharmacokinetics and pharmacodynamics of carfilzomib among patients with advanced solid tumors who had previously failed at least

Ms Fiumenero joined Vitae in January 2006 as senior vice president of finance and administration. Prior to joining Vitae Pharmaceuticals, Ms Fiumenero has spent 13 years at Bristol-Myers

The Phase II clinical trial is an open-label, dose-escalating pharmacokinetic, pharmacodynamic, efficacy and safety study of CTA018 injection in chronic kidney disease (CKD) patients with secondary hyperparathyroidism (SHPT)

The agreement covers the existing 301 Velocity Way building of approximately 163,000sqft and approximately 30 acres designed to accommodate up to an additional 542,000sqft of office space. Gilead

The company said that it plans to launch the product immediately in the US market. The carotid Wallstent is a self-expanding stent mounted on a rapid exchange delivery

Under the terms of the agreement, Sanofi-Aventis will share information with Medicines for Malaria Venture (MMV) on its malaria drugs portfolio. The portfolio includes a licensed fixed-dose combination

The suite includes a designated area for the small-scale development and manufacturing of solid dosage forms for customers’ early clinical study needs. The 2,500sqft suite is designed to

In the clinical study conducted in 16 healthy volunteers, SD-254 exhibited a pharmacokinetic profile that appears to be superior to that of venlafaxine and consistent with that required